Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - SHORT-TERM DEBT
Short-term Debt KROS - Keros Therapeutics, Inc.
1 M
LAST VALUE
-23.65%
2 YEAR CAGR
43.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR